Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of growth hormone therapy in children with Bartter syndrome and growth/development disorders
ChiCTR2500099658Phase 4Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Bartter syndrome, Growth and developmental disorders and growth disorder, sponsored by First Hospital of China Medical University. Primary endpoint: Height. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
Bartter syndromeGrowth and developmental disordersgrowth disorder
Beyond the preview
Go deeper on ChiCTR2500099658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099658.